Advances in the understanding of malignant transformation of keratinocytes: An immunohistochemical study

Journal of the European Academy of Dermatology and Venereology

Volumn 10, Issue 2, 1998, Pages 118-124

  Tucci, M G ^a   Offidani, A ^b   Lucarini, G ^c   Simonelli, L ^d   Amati, S ^c   Cellini, A ^b   Biagini, G ^c   Ricotti, G ^b  

^a INRCA   (Italy)

^b Azienda Ospedaliera Umberto I   (Italy)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Actinic keratosis; Immunosurveillance; Langerhans cells; Oncoproteins; Squamous cell carcinoma

Indexed keywords

CD1 ANTIGEN; CD11 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; KI 67 ANTIGEN; ONCOPROTEIN; PROTEIN BCL 2; PROTEIN P21; PROTEIN P53;

ACTINIC KERATOSIS; ADULT; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSURVEILLANCE; KERATINOCYTE; LANGERHANS CELL; LYMPHOCYTE COUNT; MALIGNANT TRANSFORMATION; PRECANCER; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

AGED; ANALYSIS OF VARIANCE; ANTIGENS, CD3; ANTIGENS, CD4; ANTIGENS, CD8; BIOPSY, NEEDLE; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; EPIDERMAL GROWTH FACTOR; FEMALE; HLA-DR ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; KERATINOCYTES; KERATOSIS; MALE; MIDDLE AGED; ONCOGENE PROTEINS; PRECANCEROUS CONDITIONS; SKIN NEOPLASMS;

EID: 0031931569     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0926-9959(97)00137-2     Document Type: Article

References (22)

1. Sikora N, Jams N. Immune modulation and cancer. Br Med Bull 1991;47(1):209-226.
2. Geek KS. Intraepithelial lymphocytes and immune system. Adv Immunol 1995;58:297-343.
3. Kosugi A, Yoshioka T, Suda T, et al. The activation of L3T4+ T cells assisting the generation of antitumor LyT3+ cytotoxic T lymphocytes: requirement of Ia positive antigen-presenting cells for processing, and presentation of tumor antigens. J Leukocyte Biol 1987;42:632-639.
4. Aberer W, Schuler G, Stingl G, Hunigsmann H, Wolff K. Ultraviolet light depletes surface markers of Langerhans cells. J Invest Dermatol 1981;76:202-207.
5. Stingle G, Gazze Stingle LA, Aberer W, Wolff K. Antigen presentation by murine epidermal Langerhans cells and its alteration by ultraviolet light. J Immunol 1980;124:445-450.
6. Bergstresser PR, Towes GB, Streilein JW. Natural and perturbed distributions of Langerhans cells: responses to ultraviolet light, heterotopic skin grafting, and 2-dinitrofluorobenzene sensitization. J Invest Dermatol 1980;75:73-82.
7. Simon JC, Krutman J, Elements CA, Bergstresser PR, Cruz Jr. PD. Ultraviolet B irradiated antigen presenting cells display altered accessory signaling for T cell activation: relevance to immune responses initiated in the skin. J Invest Dermatol 1992;98:665-695.
8. Nickoloff BJ, Turka LA. Immunological functions of nonprofessional antigen-presenting cells: new insights from studies of T-cell interactions with keratinocytes. Immunol Today 1994;15(10):464-469.
9. Ziegler AM, Jonason AS, Leffel DJ, Simon JA, Sharma HW, Kimmelman J, Remington L, Jacks T, Brash DE. Sunburn and p53 in the onset of skin cancer. Nature 1994;372:22-29.
10. Stintchcomb DT. Constraining the cell cycle: regulating cell division and differentiation by gene therapy. Nat Med 1995;10(1):1004-1006.
11. Wage S, Hannon GJ, Beach D, Stilman B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 1994;369 (16):574-578.
12. Anne R, Polakowska R. Cell death by apoptosis in epidermal biology. J Invest Dermatol 1993;101(2):107-111.
13. Hsu SM, Raine L, Fanger H. The use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase technique: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-581.
14. Proby CM, Menage HP, Mc Gregor S, Hobbs C, Norris PG, Harek J. p-53 Immunoreactivity in cutaneous PUVA tumors is similar to that in other non-melanoma skin neoplasms. J Cutaneous Pathol 1993;6:435-441.
15. Nanney LB, Margrid CM, Stoscheck LE. Comparison of epidermal growth factor binding and receptor distribution in normal human epidermis and epidermal appendages. J Invest Dermatol 1984;83:385-393.
16. Ohik K, Suzuki M, Stateke J, Matsu U. Expression of epidermal growth factor receptor in squamous cell carcinoma of the head and neck. Nippon Jibrinkoka 1993;96:2039-2043.
17. Lavieille JP, Brambilla E, Riva Lavieille C, Reyet E, Charachon R, Brambilla C. Immunohistochemical detection of p53 protein in preneoplastic lesions and squamous cell carcinoma of the head and neck. Acta Otolaryngol Stockh 1995; 115:334-339.
18. Schezeimer TU, Lischka G, Schaumburg-Lever G. Langerhans cells in skin tumors. Arch Dermatol 1995; 131:187-190.
19. Williams IR, Ort RJ, Kupper TS. Keratinocyte expression of B7-1 in transgenic mice amplifies the primary immune response to cutaneous antigens. Proc Natl Acad Sci USA 1994;91:12780-12784.
20. Robertson M. T-cell receptor, the present state of recognition. Nature 5;317:768-769.
21. Zuk J, Walker R. HLA class II sublocus expression in benign and malignant breast epithelium. J Pathol 1988;155:301-309.
22. Kyung-Yung L, Goedgebuure P, Linehan DC, Eberlein TJ. Immunoregulatory effects of CD4 T-helper subset in human melanoma. Surgery 1995;117:365-372.